Current topics in neuroimmunology and neuroinfectious diseases

ABSTRACT

These articles address the recent advances and future perspectives in the field of neuroinfectious diseases to try and elucidate the pathogenetic mechanisms, and identify effective treatment and preventive measures for each disease. Despite the recent remarkable diagnostic and therapeutic advances, including next-generation sequencing, bioinformatic tools, vaccines, therapeutic antibodies and antibiotics, neurological infections are major causes of permanent neurological disability.1 Although accumulating evidence has suggested the importance of complex microbe-host interactions and host immune response in determining the risk and timing of disease, and technological advances have greatly aided our knowledge of how the immune system influences the nervous system, the precise mechanism of disease pathophysiology is still incompletely understood and the treatment is still unsatisfactory.2 This issue of I Clinical and Experimental Neuroimmunology i focuses on "Neuroimmunology and neuroinfectious diseases", for which leading experts have contributed four review articles on emerging topics, including neuro-COVID-19, human prion disease, HTLV-1-associated myelopathy and Bornavirus infection. Shimohata summarizes the neuromuscular manifestations of the novel coronavirus disease 2019 (COVID-19) and adverse reactions to the COVID-19 vaccines. [Extracted from the article];Copyright of Clinical & Experimental Neuroimmunology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)